CoChat

Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease

Carrillo, Maria C., Brashear, H. Robert, Logovinsky, Veronika, Ryan, J. Michael, Feldman, Howard H., Siemers, Eric R., Abushakra, Susan, Hartley, Dean M., Petersen, Ronald C., Khachaturian, Ara S., Sperling, Reisa A. · 2013 · Alzheimer's & Dementia
Cited by 124

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Current research including the basic biology of Alzheimer's disease (AD) provides a foundation to explore whether our current state of knowledge is sufficient to initiate prevention studies and allow us to believe prevention of AD is possible. Current research and recently revised criteria for the diagnosis of AD by the National Institutes on Aging and the Alzheimer's Association suggest a continuum of disease from preclinical asymptomatic to symptomatic Alzheimer's dementia. In light of these revised criteria, the possibility of secondary prevention and even primary prevention is under discussion. The Alzheimer's Association Research Roundtable convened a meeting to discuss the rationale and feasibility of conducting secondary prevention trials in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2012.12.004

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 124

Metadata

Authors
Carrillo, M. C., Brashear, H. R., Logovinsky, V., Ryan, J. M., Feldman, H. H., Siemers, E. R., Abushakra, S., Hartley, D. M., Petersen, R. C., Khachaturian, A. S., & Sperling, R. A.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2013-02-14
Volume
9
Issue
2
Pages
123
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2120903663
Cited by
124
References
31
FWCI
14.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.jalz.2012.12.004
The paper
Carrillo, M. C., Brashear, H. R., Logovinsky, V., Ryan, J. M., Feldman, H. H., Siemers, E. R., Abushakra, S., Hartley, D. M., Petersen, R. C., Khachaturian, A. S., & Sperling, R. A. (2013). Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2012.12.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.